INmune Bio, Inc. to Participate in Alzheimer Disease Panel
Panel Session Title: Alzheimer Disease Panel Date and Time: Wednesday May 26th, 11:00 a.m. Eastern time (8:00 a.m. Pacific time) Presented by: Maxim Group LLC | Hosted by: M-Vest Moderated by: Dr. Jason McCarthy About INmune Bio, Inc. INmune Bio, Inc. is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. INmune Bio has two product platforms. The DN-TNF product platform utilizes dominant-negative technology to selectively neutralize soluble TNF, a key driver of innate immune dysfuncti...
Source: globenewswire.com